News Agencies Feed

healthcare

Jul 18

AHF to WHO: Ebola Response, Too Little, Too Late!

AHF to WHO: Ebola Response, Too Little, Too Late!

The World Health Organization (WHO) has finally declared a Public Health Emergency of International Concern (PHEIC) in the Democratic Republic of the Congo on July 17 as a long overdue acknowledgement that the current Ebola outbreak remains uncontained and still poses a significant threat to global health security. A PHEIC declaration carries legal obligations requiring affected states to cooperate with the WHO in coordinating an outbreak response plan and also puts the global public health community on notice signifying a substantial health security risk to the world. “The PHEIC declaration is a step in the right direction, but it should......

Continue Reading >>

Jul 18

Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics

Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics

Boehringer Ingelheim and Bridge Biotherapeutics Inc. today announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge Biotherapeutics’s autotaxin inhibitor BBT-877 for patients with fibrosing interstitial lung diseases, including"...

Continue Reading >>

Jul 16

AHF: Clock Is Ticking, WHO – Act Now on Ebola!

AHF: Clock Is Ticking, WHO – Act Now on Ebola!

With the first reported case of Ebola emerging this week in Goma, a populous city in the eastern Democratic Republic of the Congo (DRC) next to the Rwandan city of Gisenyi, medical care providers and public health advocates from AIDS Healthcare Foundation (AHF)"...

Continue Reading >>

Jul 16

ResMed Inc. Completes $500M Private Placement Debt Offering

ResMed Inc. Completes $500M Private Placement Debt Offering

ResMed Inc. (NYSE: RMD, ASX: RMD) announced today the successful pricing and closing of a private placement offering of $250,000,000 principal amount 3.24% senior notes due July 10, 2026, and $250,000,000 principal amount 3.45% senior notes due July 10, 2029.

Net"...

Continue Reading >>

Jul 16

CosmeSurge, the pioneer in aesthetic services, launches its 15th clinic

CosmeSurge, the pioneer in aesthetic services, launches its 15th clinic

CosmeSurge, one of the region’s most trusted brands for cosmetic and aesthetic procedures, has launched its 15th centre in the UAE and Oman. Located on the second floor of Bareen International Hospital in Mohammed Bin Zayed City, Abu Dhabi, the centre will provide innovative, high"...

Continue Reading >>

Jul 16

SpeeDx Receives Clearance from Health Canada for ResistancePlus® MG Test

SpeeDx Receives Clearance from Health Canada for ResistancePlus® MG Test

SpeeDx Pty. Ltd. today announced ResistancePlus® MG has been cleared by Health Canada and is now available for sale across all Canadian provinces (not currently available in the U.S.). The molecular diagnostic test detects the sexually transmitted infection (STI) Mycoplasma genitalium,"...

Continue Reading >>

Jul 16

New Study Investigates the Utility of Masimo ORi™, Oxygen Reserve Index, As an Indicator to Avoid Hyperoxia During General Anesthesia

New Study Investigates the Utility of Masimo ORi™, Oxygen Reserve Index, As an Indicator to Avoid Hyperoxia During General Anesthesia

Masimo (NASDAQ: MASI) announced today that in a study recently published in the Journal of Clinical Monitoring and Computing, researchers investigated the ability of Masimo ORi™ (Oxygen Reserve Index) to serve as a noninvasive indicator of the arterial partial pressure of oxygen (PaO2) during general anesthesia, to help avoid hyperoxia.1 ORi is an index of oxygenation in the moderate hyperoxic region (PaO2 range of 100 to 200 mmHg). As an “index” with a scale between 0.0 and 1.0, ORi can be trended to notify clinicians of changes in a patient’s oxygen reserve. Dr. Keisuke Yoshida and colleagues at the Fukushima Medical......

Continue Reading >>

Jul 15

Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform

Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform

Boehringer Ingelheim today announced its acquisition of all shares of AMAL Therapeutics SA, a private Swiss biotechnology company focused on cancer immunotherapy and advancing first-in-class therapeutic cancer vaccines derived from its technology platform KISIMA. AMAL’s lead vaccine"...

Continue Reading >>

Jul 14

Jabaq signs MoU with his Iraqi counterpart on joint health cooperation

Jabaq signs MoU with his Iraqi counterpart on joint health cooperation

NNA - Public Health Minister Dr. Jamil Jabaq and his Iraqi counterpart Alaa Alwan, on Friday signed a Memorandum of Understanding (MoU) to promote joint health cooperation in the pharmaceutical and hospitalization domains.


The signature comes after amending the poposed"...

Continue Reading >>

Jul 11

Morinaga Milk’s Probiotic Bifidobacterium longum BB536 Achieves Self-Affirmed GRAS for Infants in Celebration of Its 50th Anniversary

Morinaga Milk’s Probiotic Bifidobacterium longum BB536 Achieves Self-Affirmed GRAS for Infants in Celebration of Its 50th Anniversary

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Morinaga Bifidobacterium longum BB536 has received self-affirmed GRAS (Generally Recognized as Safe) for infant formulas, in honor of its 50th anniversary. Bifidobacterium longum BB536, a clinically proven multifunctional probiotic strain that was originated from the gut of a healthy breast-fed infant in 1969, is celebrating its 50th anniversary of its discovery in 2019. The probiotic strain Bifidobacterium longum BB536 had previously attained official confirmation from the U.S. Food and Drug Administration (FDA)......

Continue Reading >>